Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 208.8 SEK 0.38%
Market Cap: 28.3B SEK

Vitrolife AB
Investor Relations

Vitrolife AB is a Swedish company that has carved out a significant niche within the biotechnology sector, particularly within reproductive health. Founded in 1994, Vitrolife focuses on the development, production, and commercialization of products designed to optimize fertility treatments. The company’s offerings include a wide range of medical devices and culture media critical for in vitro fertilization (IVF) procedures. These products are used by fertility clinics across the globe, enhancing every stage of assisted reproduction — from egg retrieval and sperm preparation to embryo transfer. This comprehensive approach not only amplifies treatment outcomes but also strengthens Vitrolife's position as a pivotal player in a market where scientific advancement and patient care converge.

The company’s business model thrives on a robust combination of research-driven innovation and strategic acquisitions. By continuously refining its product lines and leveraging strategic partnerships with clinics and research institutes, Vitrolife ensures that it remains at the cutting edge of the rapidly evolving fertility landscape. Revenue streams flow in through the sales of these critical fertility products, supported by a well-established distribution network that bridges its Swedish roots with a global customer base. With a commitment to quality and efficacy, Vitrolife makes money by delivering solutions that enhance the success rates of fertility treatments, making the dream of parenthood possible for many around the world.

Show more
Loading

Earnings Calls

2024 Q3
Nov 6, 2024
Show Transcript
Previous
Next
AEP's Future Guidance and Growth Opportunities.
2024 Q3
Nov 6, 2024

In the third quarter of 2024, American Electric Power (AEP) reported operating earnings of $1.85 per share, boosting its 2024 guidance range to $5.58-$5.68 per share. AEP anticipates 2025 earnings between $5.75 and $5.95 per share, representing approximately 4% growth. The company introduced a long-term earnings growth target of 6% to 8%, supported by a robust $54 billion capital plan, up 25% from the previous plan. Retail sales are projected to rise by 8.3% in 2025, primarily driven by data center demand, aiming for 20 gigawatts of load by 2029. AEP is also committed to improving customer service and regulatory relationships, pledging to enhance operational performance.

Show Full Analysis

Management

Ms. Bronwyn Brophy O´Connor
CEO & President
No Bio Available
Mr. Patrik Tolf
Chief Financial Officer
No Bio Available
Mr. Claus Bisgaard
Senior Vice President of Technologies
No Bio Available
Guillermo Ferrando
Vice President Strategy & Corporate development
No Bio Available
Olivia Natens
Senior Vice President of Sales & Marketing
No Bio Available
Frank Pettersson
Acting Senior Vice President of HR & Sustainability
No Bio Available
Mr. Rickard Ericsson
Senior Vice President of Consumables
No Bio Available
Ricardo Capella
Senior Vice President Genetic Services
No Bio Available

Contacts

Address
VASTRA GOTALANDS
Goeteborg
Gustaf Werners Gata 2
Contacts
+46317218000.0
www.vitrolife.com